Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $5.3350 (-8.57%) ($5.3350 - $5.3350) on Mon. Aug. 15, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.63% (three month average) | RSI | 75 | Latest Price | $5.3350(-8.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 7.1% a day on average for past five trading days. | Weekly Trend | ATRA advances 32.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) LIT(73%) ACES(72%) ICLN(72%) XLU(71%) EWP(58%) | Factors Impacting ATRA price | ATRA will decline at least -5.315% in a week (0% probabilities). USO(-5%) EDOC(7%) XRT(9%) XOP(14%) UUP(-24%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -5.315% (StdDev 10.63%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.1(4.61%) | 10 Day Moving Average | $4.26(25.23%) | 20 Day Moving Average | $3.79(40.77%) | To recent high | -39.2% | To recent low | 86.9% | Market Cap | $396m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |